Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
Clinical trial NCT03784066 · UNKNOWN
Trial details
- NCT number
- NCT03784066
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-27
- Primary completion
- 2025-03-24
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.